Akums Drugs & Pharmaceuticals has announced that a meeting of its Board of Directors is scheduled for November 13, 2025. The meeting will focus on reviewing and approving the unaudited standalone and consolidated financial results for the quarter and half-year ending on September 30, 2025. This announcement provides key information regarding the company’s financial performance assessment.
Board Meeting Details
A meeting of the Board of Directors of Akums Drugs & Pharmaceuticals is scheduled to be held on Thursday, November 13, 2025. During this meeting, the board will review and approve the Un-audited (Standalone & Consolidated) Financial Results.
Financial Results Consideration
The primary agenda of the meeting is to consider and approve the financial results for the quarter and half-year, which ended on September 30, 2025.
Source: BSE
